Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Outlook Therapeutics (OTLK) Q4 2025 Earnings
OTLK
19
Dec
Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.89
-0.61
-0.34
-0.06
Details
Expected EPS
-0.26
Actual EPS
-0.06
Surprise EPS
0.2
Surprise Percent
+76.92%
Description
Outlook Therapeutics (OTLK) has reported earnings of -0.06 per share for Q4 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login